Greenwich LifeSciences, Inc. GLSI
Set alert
16.76 USD +0.30 +1.81%
As of Nov 3, 11:55 AM ET
16.70 Day range 17.21
7.85 52-week range 33.56
- YTD
- -20.24%
- 1 year
- +98.79%
- Open
- 16.70
- Prev close
- 16.46
- Mkt cap
- 245.98M
- Vol
- 19.17K
- Avg vol
- 127.91K
- EPS
- -1.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.70
- High
- 17.21
- Forward P/E
- -14.83
- Beta
- 3.32
- Short ratio
- 21.41
- Inst. own
- 8.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 13.57
- 200-d avg
- 14.65
- 1y target
- 38.00
Analyst view
Price target (mean) 38.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 23, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 20, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Sep 1, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Jan 27, 2021 | Aegis Capital | Initiated | — | Buy |
| Jan 26, 2021 | Aegis Capital | Initiated | — | Buy |